FOREJTOVA, S., H. MANN, J. STOLFA, K. VEDRAL, I. FENCLOVA, Danka NÉMETHOVÁ a K. PAVELKA. Factors influencing health status and disability of patients with ankylosing spondylitis in the Czech Republic. Clinical Rheumatology. New York: Springer, 2008, roč. 27, č. 8, s. 1005-1013. ISSN 0770-3198.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Factors influencing health status and disability of patients with ankylosing spondylitis in the Czech Republic
Název česky Factors influencing health status and disability of patients with ankylosing spondylitis in the Czech Republic
Autoři FOREJTOVA, S. (203 Česká republika), H. MANN (203 Česká republika), J. STOLFA (203 Česká republika), K. VEDRAL (203 Česká republika), I. FENCLOVA (203 Česká republika), Danka NÉMETHOVÁ (703 Slovensko, garant) a K. PAVELKA (203 Česká republika).
Vydání Clinical Rheumatology, New York, Springer, 2008, 0770-3198.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30000 3. Medical and Health Sciences
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 1.559
Kód RIV RIV/00216224:14310/08:00033761
Organizační jednotka Přírodovědecká fakulta
UT WoS 000257370000009
Klíčová slova anglicky Ankylosing spondylitis; BASDAI; Disability; HAQ-DI; Health status; Questionnaire
Štítky Ankylosing spondylitis, BASDAI, disability, HAQ-DI, health status, questionnaire
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: RNDr. Danka Haruštiaková, Ph.D., učo 163612. Změněno: 28. 6. 2009 21:58.
Anotace
The aim of the study was to evaluate factors that influence health status and work disability in patients with ankylosing spondylitis (AS) in the Czech Republic. Data were collected in a retrospective fashion directly from patients with AS using mailed questionnaires containing questions regarding sociodemographic characteristics of patients, the course of their disease, therapy, rehabilitation, quality of life, and ability to work. HAQ-DI (Health Assessment Questionnaire-Disability Index) and BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) were also included in the questionnaires; 1,008 questionnaires were suitable for further statistical analysis. The average age of patients was 50.2 years, the average symptom duration was 23.0 years. Mean time from first symptoms to diagnosis was 9.1 years. Receiving disability pension was more frequent among men (64%) compared to women (56%) (P=0.012), despite the fact that women had higher BASDAI (P<0.001) and HAQ-DI (P=0.004) scores. Fifty eight percent of patients reported a BASDAI score more than 4 (current cutoff value for initiation of biological therapy), but only 1% of patients were treated by anti TNF alpha agents within the last year.
Anotace česky
The aim of the study was to evaluate factors that influence health status and work disability in patients with ankylosing spondylitis (AS) in the Czech Republic. Data were collected in a retrospective fashion directly from patients with AS using mailed questionnaires containing questions regarding sociodemographic characteristics of patients, the course of their disease, therapy, rehabilitation, quality of life, and ability to work. HAQ-DI (Health Assessment Questionnaire-Disability Index) and BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) were also included in the questionnaires; 1,008 questionnaires were suitable for further statistical analysis. The average age of patients was 50.2 years, the average symptom duration was 23.0 years. Mean time from first symptoms to diagnosis was 9.1 years. Receiving disability pension was more frequent among men (64%) compared to women (56%) (P=0.012), despite the fact that women had higher BASDAI (P<0.001) and HAQ-DI (P=0.004) scores. Fifty eight percent of patients reported a BASDAI score more than 4 (current cutoff value for initiation of biological therapy), but only 1% of patients were treated by anti TNF alpha agents within the last year.
Návaznosti
MSM0021622412, záměrNázev: Interakce mezi chemickými látkami, prostředím a biologickými systémy a jejich důsledky na globální, regionální a lokální úrovni (INCHEMBIOL) (Akronym: INCHEMBIOL)
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Interakce mezi chemickými látkami, prostředím a biologickými systémy a jejich důsledky na globální , regionální a lokální úrovni
VytisknoutZobrazeno: 25. 4. 2024 10:44